PROMETHEUS: Long-Term Exacerbation and Mortality Benefits of Implementing Single-Inhaler Triple Therapy in the US COPD Population

Background: The US population includes 24 million to 29 million people with diagnosed and undiagnosed chronic obstructive pulmonary disease (COPD). Studies have demonstrated the safety and efficacy of single-inhaler triple therapy (SITT) in reducing COPD exacerbations. Long-term population implicati...

Descripción completa

Detalles Bibliográficos
Autores principales: Criner, Gerard, Martinez, Fernando, Gandhi, Hitesh, Feigler, Norbert, Pyenson, Bruce, Emery, Matthew, Gupta, Umang, Vaduganathan, Muthiah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Columbia Data Analytics, LLC 2023
Materias:
Respiratory Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879267/
https://www.ncbi.nlm.nih.gov/pubmed/36742194
http://dx.doi.org/10.36469/001c.55635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879267/
https://www.ncbi.nlm.nih.gov/pubmed/36742194
http://dx.doi.org/10.36469/001c.55635

Ejemplares similares